← Leaderboards
Sutip Navankasattusas
Navigen, Inc.
$2,784,365
Attributed
$2,784,365
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $860.9K · FY2008–11$1M$750K$500K$250K$0
'08
'09
'10
'11
Funding mix
By agency
NIH$2,784,365 · 6
By mechanism
R44$1,757,850 · 2
R43$1,026,515 · 4
Top collaborators
No co-investigators on record.
Most similar at Navigen, Inc.
Same institution · by research overlap
- Kirill Ostanin$2,281,127
- Alan L Mueller$15,252,253
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsRecombinantsBlood VesselsInflammatoryCytokinePermeabilityLigandsReceptorIn VitroIn VivoAgonistVascular SystemInjuryInfectionMortality Vital StatisticsAnimalsEpithelialInflammatory ResponsePandemic InfluenzaBaseDrug KineticsAlveolarAnimal ModelGrowth Factor
Grant awards (8)
Novel Therapeutic Approach to Acute Lung Injury$567,237
R44 · FY2011 · HL · contact PI
SLIT2N for the treatment of influenza-induced acute respiratory distress$293,656
R43 · FY2011 · AI · contact PI
Novel Therapeutic Approach to Acute Lung Injury$554,199
R44 · FY2010 · HL · contact PI
SLIT2N for the treatment of influenza-induced acute respiratory distress$298,200
R43 · FY2010 · AI · contact PI
Anti-HTRA1 Therapy For AMD$636,414
R44 · FY2009 · EY · contact PI
Novel Therapeutic Approach to Acute Lung Injury$147,660
R43 · FY2008 · HL · contact PI
Targeting HTRA 1 for the Treatment of Age Related Macular Degeneration$146,999
R43 · FY2008 · EY · contact PI
Inhibiting pathologic angiogenesis and vascular leak in the eye.$140,000
R43 · FY2008 · EY · contact PI